Cargando…
Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084997/ https://www.ncbi.nlm.nih.gov/pubmed/33927190 http://dx.doi.org/10.1038/s41408-021-00471-x |
| _version_ | 1783686256940548096 |
|---|---|
| author | Jentzsch, Madlen Grimm, Juliane Bill, Marius Brauer, Dominic Backhaus, Donata Schulz, Julia Goldmann, Karoline Niederwieser, Dietger Platzbecker, Uwe Schwind, Sebastian |
| author_facet | Jentzsch, Madlen Grimm, Juliane Bill, Marius Brauer, Dominic Backhaus, Donata Schulz, Julia Goldmann, Karoline Niederwieser, Dietger Platzbecker, Uwe Schwind, Sebastian |
| author_sort | Jentzsch, Madlen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8084997 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80849972021-05-05 Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation Jentzsch, Madlen Grimm, Juliane Bill, Marius Brauer, Dominic Backhaus, Donata Schulz, Julia Goldmann, Karoline Niederwieser, Dietger Platzbecker, Uwe Schwind, Sebastian Blood Cancer J Correspondence Nature Publishing Group UK 2021-04-29 /pmc/articles/PMC8084997/ /pubmed/33927190 http://dx.doi.org/10.1038/s41408-021-00471-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Jentzsch, Madlen Grimm, Juliane Bill, Marius Brauer, Dominic Backhaus, Donata Schulz, Julia Goldmann, Karoline Niederwieser, Dietger Platzbecker, Uwe Schwind, Sebastian Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation |
| title | Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation |
| title_full | Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation |
| title_fullStr | Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation |
| title_full_unstemmed | Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation |
| title_short | Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation |
| title_sort | prognostic relevance of remission and measurable residual disease status in aml patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084997/ https://www.ncbi.nlm.nih.gov/pubmed/33927190 http://dx.doi.org/10.1038/s41408-021-00471-x |
| work_keys_str_mv | AT jentzschmadlen prognosticrelevanceofremissionandmeasurableresidualdiseasestatusinamlpatientspriortoreducedintensityornonmyeloablativeallogeneicstemcelltransplantation AT grimmjuliane prognosticrelevanceofremissionandmeasurableresidualdiseasestatusinamlpatientspriortoreducedintensityornonmyeloablativeallogeneicstemcelltransplantation AT billmarius prognosticrelevanceofremissionandmeasurableresidualdiseasestatusinamlpatientspriortoreducedintensityornonmyeloablativeallogeneicstemcelltransplantation AT brauerdominic prognosticrelevanceofremissionandmeasurableresidualdiseasestatusinamlpatientspriortoreducedintensityornonmyeloablativeallogeneicstemcelltransplantation AT backhausdonata prognosticrelevanceofremissionandmeasurableresidualdiseasestatusinamlpatientspriortoreducedintensityornonmyeloablativeallogeneicstemcelltransplantation AT schulzjulia prognosticrelevanceofremissionandmeasurableresidualdiseasestatusinamlpatientspriortoreducedintensityornonmyeloablativeallogeneicstemcelltransplantation AT goldmannkaroline prognosticrelevanceofremissionandmeasurableresidualdiseasestatusinamlpatientspriortoreducedintensityornonmyeloablativeallogeneicstemcelltransplantation AT niederwieserdietger prognosticrelevanceofremissionandmeasurableresidualdiseasestatusinamlpatientspriortoreducedintensityornonmyeloablativeallogeneicstemcelltransplantation AT platzbeckeruwe prognosticrelevanceofremissionandmeasurableresidualdiseasestatusinamlpatientspriortoreducedintensityornonmyeloablativeallogeneicstemcelltransplantation AT schwindsebastian prognosticrelevanceofremissionandmeasurableresidualdiseasestatusinamlpatientspriortoreducedintensityornonmyeloablativeallogeneicstemcelltransplantation |